Horizon Pharma plc to Present at Two Conferences in December
Get Alerts HZNP Hot Sheet
Join SI Premium – FREE
DUBLIN, IRELAND -- (Marketwired) -- 11/19/15 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it will be presenting at the following conferences the first week in December:
27th Annual Piper Jaffray Healthcare Conference
- Presentation Date: December 1, 2015
- Presentation Time: 2 p.m. EST
- Location: New York
Bank of America Merrill Lynch 2015 Leveraged Finance Conference
- Presentation Date: December 3, 2015
- Presentation Time: 10:50 a.m. EST
- Location: Boca Raton
The presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of each webcast will be available following the events.
About Horizon Pharma plc Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon Pharma's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts: Investors: John Thomas Executive Vice President, Corporate Strategy and Investor Relations [email protected] Tina Ventura Vice President, Investor Relations [email protected] Media: Geoff Curtis Group Vice President, Corporate Communications [email protected]
Source: Horizon Pharma plc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tudor Gold Discovers Higher-Grade Silver Breccia within CBS Zone at Treaty Creek
- HC Private Investments Announces Sale of Epicurean Butter to Solina USA
- Aptera Motors Receives EPA Certificate of Conformity for 2026 Launch Edition, Marking a Key Regulatory Milestone
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Piper Jaffray, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share